Diabetes medications included insulin (39.1%) and oral hypoglycaemic agents [sulfonylureas (n = 189; 23.6%), dipeptidyl peptidase-4 inhibitors (n = 249; 31.1%) and metformin (n = 481; 60.0%)]. This evidence concerns the gene INS and diabetes mellitus.